Global Thawing Systems Market Report 2023: Players Include Antrad Medical, Biolife Solutions, Boekel Scientific, Cardinal Health and Cytiva Life Sciences

DUBLIN, May 3, 2023 /PRNewswire/ -- The "Thawing Systems: Global Markets" report has been added to  ResearchAndMarkets.com's offering.

The global thawing systems market is estimated to reach $314.4 million in 2027 from $242.2 million in 2022 at a CAGR of 7.1%

Companies Mentioned

• Antrad Medical Ab
• Biolife Solutions Inc.
• Boekel Scientific.
• Cardinal Health
• Cytiva Life Sciences
• Fremon Scientific Inc.
• Helmer Scientific Inc.
• Kw Scientific Devices Srl
• Sarstedt AG & Co.
• Sartorius
• Stericox India Private Limited

Organelles, cells, tissues, and other biological constructions can all be preserved by a method called cryopreservation, where they are cooled to extremely low temperatures.

The reactions of living organisms to ice formation are both theoretically fascinating and practically useful. For the best cryopreservation and recovery, a controlled rate of freezing and quick thawing is required. Transient warming episodes during transfer and storage must be minimized since they affect viability and recovery. Compared to passive thawing, active thawing increases cell viability and recovery.

Transfusions of blood are a crucial therapeutic strategy. In an emergency, we might all use blood, and some of us require transfusions frequently. A transfusion is performed to provide the patient with the blood component(s) that will improve their physiological condition. A single gift of whole blood can be used to produce several different blood components.

Red blood cells and plasma components can typically be separated in blood banks. Others can manufacture ingredients like cryoprecipitate and platelet concentrates. Blood is drawn from the patient at body temperature or 37 C. However, it must be chilled to below +10 C for transportation and kept at refrigeration temperatures of roughly +4 C until use to preserve its essential qualities. In that step, blood-thawing devices are required.

Before being used in IVF, a previously frozen sperm sample is recovered and processed using a sperm thaw method. The patient's sperm sample is located. The vial is taken out of liquid nitrogen storage, and its accuracy is checked against the patient's records. The sample is subsequently warmed in thawing equipment or a water bath, and the concentration, motility, and progression of the sperm are assessed. It's a good idea to have a backup plan in case something goes wrong.

Using automation and slower thawing rates, dry thawing systems improve consistency between thawing operations while reducing cell cryoprotectant degradation.

Report Includes

• 25 tables
• An overview of the global markets for thawing systems
• Estimation of market size and analyses of global market trends, with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
• Coverage of history and principles of cryopreservation, and discussion on impact of cryopreservation and freeze-thawing on therapeutic properties
• Assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the thawing systems market
• Discussion on the implications of thawing systems in the context of the current size and growth of the medical device market, and description of important technologies that supports thawing devices
• Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights
2.1 Market Size and Evolution

Chapter 3 Market Overview
3.1 History and Principles of Cryopreservation
3.1.1 Principles of Cryopreservation
3.2 Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties
3.2.1 Hematopoietic Stem and Progenitor Cells (Hspcs)
3.2.2 Mesenchymal Stromal/Stem Cells (Mscs)
3.2.3 Other Common Cellular Therapeutics
3.3 Guide to Cell Thawing
3.3.1 Controlled Cooling for Stable Thawing
3.3.2 Ice Formation During Cooling
3.3.3 Post-Thaw Toxicity
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.2 Market Restraints
3.4.3 Opportunity
3.5 Impact of Covid-19 on the Thawing System Market

Chapter 4 Global Market Breakdown
4.1 Overview
4.2 Global Market of Thawing Systems, by Sample Type
4.2.1 Blood
4.2.2 Stem Cell
4.2.3 Embryo and Ovum
4.2.4 Semen
4.3 Global Market of Thawing Systems, by End-user
4.3.1 Biotechnology and Pharma Companies
4.3.2 Blood Banks and Transfusion Centers
4.3.3 Hospitals and Diagnostic Centers
4.3.4 Academic and Research Institutes

Chapter 5 Market Breakdown, by Region

Chapter 6 Industry Trends and Emerging Technologies
6.1 Competitive Landscape
6.2 Emerging Technologies

Chapter 7 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/h6864c

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets